CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This research study involves testing the safety and efficacy of an investigational intervention for patients with triple-negative b ...
Phase 2
Chapel Hill, North Carolina, United States and 9 other locations
This randomized phase II trial studies how well carboplatin with or without atezolizumab works in treating patients with stage IV triple negative...
Phase 2
Chapel Hill, North Carolina, United States and 5 other locations
This research study is studying Ruxolitinib as possible treatment for Inflammatory Breast Cancer (IBC).The Following drugs will be ...
Phase 2
Durham, North Carolina, United States and 3 other locations
doxorubicin and cyclophosphamide (AC) or epirubicin and cyclophosphamide (EC). Usually, after neoadjuvant therapy and surgery for triple ne ...
Phase 3
Cary, North Carolina, United States and 216 other locations
avelumab with sacituzumab govitecan works in treating patients with triple negative breast cancer that is stage I...
Phase 2
Durham, North Carolina, United States and 11 other locations
or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after su...
Phase 3
Durham, North Carolina, United States and 160 other locations
study explores the safety of escalating doses of chimeric antigen receptor T cells (CAR-T) cells in subjects with relapsed/refractory triple-...
Phase 1
Chapel Hill, North Carolina, United States
(pembrolizumab) and chemotherapy for lymph node-positive, triple negative (TN) or hormone receptor positive/HER2-negative ...
Phase 2
Durham, North Carolina, United States and 9 other locations
(ABBV-181) and/or chemotherapy in participants with selected solid tumors. This study consists of 2 main parts, a dose-escalation phase and ...
Phase 1
Durham, North Carolina, United States and 25 other locations
(HCC), pancreatic ductal adenocarcinoma (PDAC), biliary tract cancers (BTC), esophageal squamous cell carcinoma (ESCC), triple negative...
Phase 1
Durham, North Carolina, United States and 39 other locations
Clinical trials
Research sites
Resources
Legal